Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
budesonide + vitamin d
- Development stage
- Preclinical
- Modality
- Small Molecules
- Administration
- Inhalation, Oral
01
Overview
A combination therapy consisting of budesonide (a corticosteroid) and vitamin D (specifically vitamin D3 or cholecalciferol). Budesonide works by reducing inflammation through suppressing certain immune responses, while vitamin D plays roles in immune function regulation and may have protective effects on the respiratory tract. This combination has been studied for respiratory conditions including asthma and COPD, with research suggesting budesonide can up-regulate vitamin D receptor expression and enhance vitamin D's inhibitory effect on airway remodeling.
02
Targets
GR (Glucocorticoid receptor)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on budesonide + vitamin d.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on budesonide + vitamin d.